Retatrutide 12MG-
SLU-PP 322
5 Amino 1 MQ 10MG
MOT-C 10MG
Retatrutide is a novel investigational peptide that functions as a triple receptor agonist—targeting GLP-1, GIP, and glucagon receptors. This multifaceted mechanism is being actively studied for its ability to enhance metabolic function, reduce body weight, and improve insulin sensitivity more effectively than single or dual agonists.
SLU-PP-332 is a novel, high-purity research compound identified as a potent pan-agonist for the Estrogen-Related Receptors (ERRs). As a member of the “exercise mimetic” class of compounds, it is an invaluable tool for researchers. Its primary application is in laboratory settings for the advanced study of how ERR pathways influence cellular metabolism, metabolic health, mitochondrial function, muscle endurance, and age-related energy decline.
5-Amino-1MQ is a small molecule compound and potent NNMT (nicotinamide N-methyltransferase) inhibitor, widely studied for its effects on energy metabolism, fat oxidation, and cellular longevity. By modulating NNMT activity, 5-Amino-1MQ has been shown in research settings to support the upregulation of NAD⁺ levels, a critical coenzyme in mitochondrial health and aging pathways.
MOTS-c is a naturally occurring mitochondrial-derived peptide (MDP) encoded within the 12S rRNA of mitochondrial DNA. It plays a regulatory role in cellular metabolism and has been the subject of research into insulin sensitization, fatty acid oxidation, and stress resistance pathways, particularly in skeletal muscle and liver models.
All products are shipped in lyphollized or powder form and must be reconstituted to a liquid for research and testing. We are unable to provide any dosing instructions, however all products should be considered pharmaceutical grade.
Intended exclusively for research use only and not for human consumption, medical, veterinary, or household uses. Proper safety protocols must be followed. Please see out Terms & Conditions for more details.